Table 4.
Details of adverse outcome.
Site of metastases | PTC-GD | Euthyroid |
---|---|---|
Bone | 2 (6.8%) | 1 (0.4%) |
Lung | 0 | 2 (0.8%) |
Bone + lung | 2 (6.8%) | 4 (1.6%) |
Local recurrence + lung | 0 | 3 (1.3%) |
Local recurrence + lung + bone | 0 | 3 (1.3%) |
Local recurrence | 1 (3.4%) | 4 (1.7%) |